Health Condition 1: I10- Essential (primary) hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Individuals between the ages of eighteen to thirty-five years. 2) Diagnosed or undiagnosed cases of stress-induced essential hypertension, defined as systolic blood pressure of one hundred thirty millimeters of mercury or higher and/or diastolic blood pressure of eighty millimeters of mercury or higher. 3) Participants experiencing chronic stress due to factors such as work-related pressures, marital conflicts, low socioeconomic status, or lack of social support. 4) Individuals of both male and female genders who are willing to participate in the study and adhere to the treatment and follow-up schedule. 5) Participants who are not currently taking any medications for high blood pressure. 6) Individuals without any history of substance abuse, including alcohol or drug use, and without any critical systemic diseases or severe medical conditions.
Exclusion criteria
Exclusion criteria: 1) Individuals who are outside the age range of eighteen to thirty-five years. 2) Participants who have irregular follow-up or are unwilling to comply with the study protocol. 3) Individuals who have been diagnosed with hypertension and are currently receiving any form of medication for high blood pressure. 4) Participants with a history of substance abuse, including long-term alcohol consumption or drug use. 5) Cases with severe medical conditions or poor health prognosis that may interfere with their ability to participate in the study. 6) Individuals diagnosed with systemic diseases, including kidney disorders, liver diseases, or heart conditions. 7) Women who are pregnant or breastfeeding. Participants who are undergoing any other complementary or alternative treatments for high blood pressure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in Systolic and Diastolic Blood Pressure (measured in millimeters of mercury)Timepoint: Baseline, 4 weeks & 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessed using validated questionnaires or scalesTimepoint: Measured at baseline, at four weeks, at eight weeks, & at the end of the six-month treatment period. | — |
Countries
India
Contacts
Vidhyadeep Homoeopathic Medical College And Research Centre Vidhyadeep University